These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28895045)

  • 1. Influence of Gd-EOB-DTPA on proton density fat fraction using the six-echo Dixon method in 3 Tesla magnetic resonance imaging.
    Hayashi T; Fukuzawa K; Kondo H; Onodera H; Toyotaka S; Tojo R; Yano S; Tano M; Miyati T; Kotoku J; Okamoto T; Toyoda K; Oba H
    Radiol Phys Technol; 2017 Dec; 10(4):483-488. PubMed ID: 28895045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Gd-EOB-DTPA on T1 dependence of the proton density fat fraction using magnetic resonance spectroscopy.
    Hayashi T; Fukuzawa K; Kondo H; Onodera H; Tojo R; Yano S; Miyati T; Kotoku J; Okamoto T; Toyoda K; Oba H
    Radiol Phys Technol; 2018 Sep; 11(3):338-344. PubMed ID: 29858768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Gadoxetate disodium to the hepatic proton density fat fraction quantified with the Dixon sequences in a rabbit model.
    Wang X; Zhang S; Huang Z; Tian G; Liu X; Chen L; An L; Li X; Liu N; Ji Y; Han Y
    Abdom Radiol (NY); 2024 Oct; 49(10):3374-3382. PubMed ID: 38683216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Gd-EOB-DTPA on proton-density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging at 3-T.
    Suzuki M; Hayashi T; Nashiki K; Kawata H; Nagata S; Abe T
    Radiol Phys Technol; 2024 Sep; 17(3):637-644. PubMed ID: 38730134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI.
    Sofue K; Zhong X; Nickel MD; Dale BM; Bashir MR
    Abdom Radiol (NY); 2016 Aug; 41(8):1555-64. PubMed ID: 27052456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of six-point modified dixon and magnetic resonance spectroscopy for fat quantification: a fat-water-iron phantom study.
    Fukuzawa K; Hayashi T; Takahashi J; Yoshihara C; Tano M; Kotoku J; Saitoh S
    Radiol Phys Technol; 2017 Sep; 10(3):349-358. PubMed ID: 28770394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Gd-EOB-DTPA on hepatic fat quantification using high-speed T2-corrected multi-echo acquisition in (1)H MR spectroscopy.
    Park YS; Lee CH; Kim JH; Kim BH; Kim JH; Kim KA; Park CM
    Magn Reson Imaging; 2014 Sep; 32(7):886-90. PubMed ID: 24853467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the fat fraction in the liver using dual-energy computed tomography and multimaterial decomposition.
    Hur BY; Lee JM; Hyunsik W; Lee KB; Joo I; Han JK; Choi BI
    J Comput Assist Tomogr; 2014; 38(6):845-52. PubMed ID: 25162291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging.
    Yoon JH; Lee JM; Paek M; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1775-82. PubMed ID: 26373756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Gd-DTPA concentration in neuroimaging using T₁3D MP-RAGE sequence at 3.0 T.
    Xu F; Han H; Zhang H; Pi J; Fu Y
    Magn Reson Imaging; 2011 Jul; 29(6):827-34. PubMed ID: 21550743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T.
    Park CC; Hamilton G; Desai A; Zand KA; Wolfson T; Hooker JC; Costa E; Heba E; Clark L; Gamst A; Loomba R; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Apr; 42(4):1189-1198. PubMed ID: 28028556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast-to-noise ratio for liver parenchyma of the large arterial blood maximum density of Gd-EOB-DTPA and Gd-DTPA in first pass dynamic study (3D-FSPGR technique)].
    Murakami K; Yoshida K; Kakuba K; Yanagimoto S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2009 Mar; 65(3):301-5. PubMed ID: 19367063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, multivendor phantom study to validate proton density fat fraction and T2* values calculated using vendor-provided 6-point DIXON methods.
    Hayashi T; Fukuzawa K; Yamazaki H; Konno T; Miyati T; Kotoku J; Oba H; Kondo H; Toyoda K; Saitoh S
    Clin Imaging; 2018; 51():38-42. PubMed ID: 29425901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.
    Böttcher J; Hansch A; Pfeil A; Schmidt P; Malich A; Schneeweiss A; Maurer MH; Streitparth F; Teichgräber UK; Renz DM
    Eur J Radiol; 2013 Nov; 82(11):1860-9. PubMed ID: 23932636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MR angiography in rats with hepatobiliary contrast agents.
    Yoshikawa K; Inoue Y; Shimada M; Akahane M; Itoh S; Seno A; Hayashi S
    Magn Reson Imaging; 2004 Sep; 22(7):937-42. PubMed ID: 15288134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.